Finepoint discloses 5.7% RXO stake in Schedule 13G
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Finepoint Capital LP and Herbert Wagner reported a significant passive stake in RXO, Inc. common stock on a Schedule 13G. They beneficially own 9,388,789 shares of RXO common stock, representing 5.7% of the class, with shared voting and dispositive power over all of these shares.
The percentage is based on 164,111,872 RXO shares outstanding as of November 4, 2025, as disclosed in RXO’s Form 10-Q for the quarter ended September 30, 2025. Finepoint acts as investment adviser to affiliated funds that directly hold the shares. The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of RXO.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What RXO (RXO) ownership did Finepoint Capital disclose in this Schedule 13G?
How did Finepoint’s RXO (RXO) ownership percentage of 5.7% get calculated?
Is Finepoint Capital’s RXO (RXO) stake intended to influence control of the company?
Who are the reporting persons in the RXO (RXO) Schedule 13G filing?
When did Finepoint’s RXO (RXO) ownership position trigger this Schedule 13G filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.